Copyright Reports & Markets. All rights reserved.

Global Contrast Media/Contrast Agents Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Contrast Media/Contrast Agents Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Contrast Media/Contrast Agents Market Size Growth Rate by Product
      • 1.4.2 Iodinated
      • 1.4.3 Gadolinium-Based
      • 1.4.4 Barium-Based
    • 1.5 Market by End User
      • 1.5.1 Global Contrast Media/Contrast Agents Market Size Growth Rate by End User
      • 1.5.2 Cardiology
      • 1.5.3 Oncology
      • 1.5.4 Neurology
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Contrast Media/Contrast Agents Market Size
      • 2.1.1 Global Contrast Media/Contrast Agents Revenue 2014-2025
      • 2.1.2 Global Contrast Media/Contrast Agents Sales 2014-2025
    • 2.2 Contrast Media/Contrast Agents Growth Rate by Regions
      • 2.2.1 Global Contrast Media/Contrast Agents Sales by Regions
      • 2.2.2 Global Contrast Media/Contrast Agents Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Contrast Media/Contrast Agents Sales by Manufacturers
      • 3.1.1 Contrast Media/Contrast Agents Sales by Manufacturers
      • 3.1.2 Contrast Media/Contrast Agents Sales Market Share by Manufacturers
      • 3.1.3 Global Contrast Media/Contrast Agents Market Concentration Ratio (CR5 and HHI)
    • 3.2 Contrast Media/Contrast Agents Revenue by Manufacturers
      • 3.2.1 Contrast Media/Contrast Agents Revenue by Manufacturers (2014-2019)
      • 3.2.2 Contrast Media/Contrast Agents Revenue Share by Manufacturers (2014-2019)
    • 3.3 Contrast Media/Contrast Agents Price by Manufacturers
    • 3.4 Contrast Media/Contrast Agents Manufacturing Base Distribution, Product Types
      • 3.4.1 Contrast Media/Contrast Agents Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Contrast Media/Contrast Agents Product Type
      • 3.4.3 Date of International Manufacturers Enter into Contrast Media/Contrast Agents Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Contrast Media/Contrast Agents Sales by Product
    • 4.2 Global Contrast Media/Contrast Agents Revenue by Product
    • 4.3 Contrast Media/Contrast Agents Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Contrast Media/Contrast Agents Breakdown Data by End User

    6 North America

    • 6.1 North America Contrast Media/Contrast Agents by Countries
      • 6.1.1 North America Contrast Media/Contrast Agents Sales by Countries
      • 6.1.2 North America Contrast Media/Contrast Agents Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Contrast Media/Contrast Agents by Product
    • 6.3 North America Contrast Media/Contrast Agents by End User

    7 Europe

    • 7.1 Europe Contrast Media/Contrast Agents by Countries
      • 7.1.1 Europe Contrast Media/Contrast Agents Sales by Countries
      • 7.1.2 Europe Contrast Media/Contrast Agents Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Contrast Media/Contrast Agents by Product
    • 7.3 Europe Contrast Media/Contrast Agents by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Contrast Media/Contrast Agents by Countries
      • 8.1.1 Asia Pacific Contrast Media/Contrast Agents Sales by Countries
      • 8.1.2 Asia Pacific Contrast Media/Contrast Agents Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Contrast Media/Contrast Agents by Product
    • 8.3 Asia Pacific Contrast Media/Contrast Agents by End User

    9 Central & South America

    • 9.1 Central & South America Contrast Media/Contrast Agents by Countries
      • 9.1.1 Central & South America Contrast Media/Contrast Agents Sales by Countries
      • 9.1.2 Central & South America Contrast Media/Contrast Agents Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Contrast Media/Contrast Agents by Product
    • 9.3 Central & South America Contrast Media/Contrast Agents by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Contrast Media/Contrast Agents by Countries
      • 10.1.1 Middle East and Africa Contrast Media/Contrast Agents Sales by Countries
      • 10.1.2 Middle East and Africa Contrast Media/Contrast Agents Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Contrast Media/Contrast Agents by Product
    • 10.3 Middle East and Africa Contrast Media/Contrast Agents by End User

    11 Company Profiles

    • 11.1 Guerbet Group
      • 11.1.1 Guerbet Group Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Guerbet Group Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Guerbet Group Contrast Media/Contrast Agents Products Offered
      • 11.1.5 Guerbet Group Recent Development
    • 11.2 Bayer Healthcare
      • 11.2.1 Bayer Healthcare Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Bayer Healthcare Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Bayer Healthcare Contrast Media/Contrast Agents Products Offered
      • 11.2.5 Bayer Healthcare Recent Development
    • 11.3 Bracco Diagnostic
      • 11.3.1 Bracco Diagnostic Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bracco Diagnostic Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bracco Diagnostic Contrast Media/Contrast Agents Products Offered
      • 11.3.5 Bracco Diagnostic Recent Development
    • 11.4 Covidien
      • 11.4.1 Covidien Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Covidien Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Covidien Contrast Media/Contrast Agents Products Offered
      • 11.4.5 Covidien Recent Development
    • 11.5 GE Healthcare
      • 11.5.1 GE Healthcare Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 GE Healthcare Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 GE Healthcare Contrast Media/Contrast Agents Products Offered
      • 11.5.5 GE Healthcare Recent Development
    • 11.6 Eli Lilly
      • 11.6.1 Eli Lilly Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Eli Lilly Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Eli Lilly Contrast Media/Contrast Agents Products Offered
      • 11.6.5 Eli Lilly Recent Development
    • 11.7 Alseres Pharmaceuticals
      • 11.7.1 Alseres Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Alseres Pharmaceuticals Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Alseres Pharmaceuticals Contrast Media/Contrast Agents Products Offered
      • 11.7.5 Alseres Pharmaceuticals Recent Development
    • 11.8 Aposense
      • 11.8.1 Aposense Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Aposense Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Aposense Contrast Media/Contrast Agents Products Offered
      • 11.8.5 Aposense Recent Development
    • 11.9 Yangtze River Pharmaceutical
      • 11.9.1 Yangtze River Pharmaceutical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Yangtze River Pharmaceutical Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Yangtze River Pharmaceutical Contrast Media/Contrast Agents Products Offered
      • 11.9.5 Yangtze River Pharmaceutical Recent Development
    • 11.10 Jiangsu Hengrui Medicine
      • 11.10.1 Jiangsu Hengrui Medicine Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Jiangsu Hengrui Medicine Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Jiangsu Hengrui Medicine Contrast Media/Contrast Agents Products Offered
      • 11.10.5 Jiangsu Hengrui Medicine Recent Development
    • 11.11 Shanghai Xudong Haipu Pharmaceutical

    12 Future Forecast

    • 12.1 Contrast Media/Contrast Agents Market Forecast by Regions
      • 12.1.1 Global Contrast Media/Contrast Agents Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Contrast Media/Contrast Agents Revenue Forecast by Regions 2019-2025
    • 12.2 Contrast Media/Contrast Agents Market Forecast by Product
      • 12.2.1 Global Contrast Media/Contrast Agents Sales Forecast by Product 2019-2025
      • 12.2.2 Global Contrast Media/Contrast Agents Revenue Forecast by Product 2019-2025
    • 12.3 Contrast Media/Contrast Agents Market Forecast by End User
    • 12.4 North America Contrast Media/Contrast Agents Forecast
    • 12.5 Europe Contrast Media/Contrast Agents Forecast
    • 12.6 Asia Pacific Contrast Media/Contrast Agents Forecast
    • 12.7 Central & South America Contrast Media/Contrast Agents Forecast
    • 12.8 Middle East and Africa Contrast Media/Contrast Agents Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Contrast Media/Contrast Agents Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Contrast media/contrast agents are chemicals used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
      Iodinated contrast media is the most widely preferred, as it can be easily administered orally.
      The global Contrast Media/Contrast Agents market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contrast Media/Contrast Agents market based on company, product type, end user and key regions.

      This report studies the global market size of Contrast Media/Contrast Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contrast Media/Contrast Agents in these regions.
      This research report categorizes the global Contrast Media/Contrast Agents market by top players/brands, region, type and end user. This report also studies the global Contrast Media/Contrast Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Guerbet Group
      Bayer Healthcare
      Bracco Diagnostic
      Covidien
      GE Healthcare
      Eli Lilly
      Alseres Pharmaceuticals
      Aposense
      Yangtze River Pharmaceutical
      Jiangsu Hengrui Medicine
      Shanghai Xudong Haipu Pharmaceutical

      Market size by Product
      Iodinated
      Gadolinium-Based
      Barium-Based
      Market size by End User
      Cardiology
      Oncology
      Neurology
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Contrast Media/Contrast Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Contrast Media/Contrast Agents market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Contrast Media/Contrast Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Contrast Media/Contrast Agents submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Contrast Media/Contrast Agents are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contrast Media/Contrast Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now